- Research
- Open access
- Published:
Molecular evidence of hepatozoonosis in tigers of Vidarbha region of Maharashtra State of India
BMC Veterinary Research volume 20, Article number: 387 (2024)
Abstract
Background
Hepatozoonosis has been reported in many species around the world. Few incidences have been reported in various species of wild felids. Tigers are endangered large cats and are protected under the Wildlife Protection Act, 1972 under Schedule I. The study was carried out to estimate the positivity rate of hepatozoonosis in tigers of the Vidarbha region of Maharashtra, India.
Methods
Blood (n = 21) or tissue samples (n = 5) were collected from 26 wild captured / zoo-born or dead tigers during the quarantine period/post-mortem examination. Blood smear examination along with Polymerase Chain Reaction (PCR) studies were conducted for the detection of hepatozoonosis. All the amplicons from the positive samples were purified and sequenced, and the sequences were subjected to nBLAST analysis to detect the species of Hepatozoon. The sequences were deposited into public domain database of National Center for Biotechnology Information (NCBI) and accession numbers were allotted. A phylogenetic study was undertaken to understand the evolutionary lineage of the pathogen. Tissue distribution studies were carried out on tissue samples received during post mortem. A clinical case in a tiger cub was managed and sub-clinical cases were monitored for relapse. Age-wise, sex-wise, region-wise and captive time-wise positivity rate was estimated. The data was analyzed using statistical tools.
Results
A total of 12 tigers were found positive for H. felis during the screening. A clinical case was diagnosed and successfully treated. The age group of 0–3 years reported a positivity rate of 66.66%, and all the cases found positive were reported between the age group of 0–7 years. Males reported a positivity rate of 58.33 per cent, while females reported 35.71%. Taboba and Andhari Tiger Reserve of the state had a positivity rate of 52.94 per cent. However, the statistical analysis for blood parameters and positivity rate by ‘t’ test and Chi-squared test were found to be non-significant.
Conclusions
An overall positivity rate of 46.15% indicates the wide distribution of hepatozoonosis among wild tigers of the Vidarbha region of Maharashtra, India, which is strategically important considering the gene flow and migration of tigers. Hepatozoonosis can progress to clinical outcomes in young animals and require veterinary intervention. Molecular tools and phylogenetic studies can supplement important data on circulating species of Hepatozoon in the field. Further studies on the clinical management and epidemiology of the infection in wild felids will comprehend the cause of wildlife conservation.
Background
India is a megadiversity hotspot that is home to three-quarters of the world’s tiger population. According to the 2018 census, the tiger population is estimated to be 2967 [1]. The tropical climate of the Indian subcontinent is not only conducive to the proliferation of flora and fauna but also to many disease vectors such as ticks. Rhipicephalus and Amblyomma spp. are commonly detected in large cats in this region. A wide array of diseases transmitted by ticks has been identified in companion species, such as dogs and cats [2]; however, India has reported only a few cases of tick-borne illnesses in the wild population [3,4,5]. Hepatozoonosis is a tick-borne infection transmitted by Rhipicephalus spp. and Amblyomma spp. ticks. Recently, Rhipicephalus turanicus was identified as a vector for transmitting H. canis [6]. The dog is the definitive host, and reports of co-infection with other tick-borne diseases have been reported in the species [7, 8], and wildlife [9,10,11]. Various protocols have been designed to treat hepatozoonosis in companions and wild animals. Monodrug therapies with oxytetracycline and doxycycline [12] have been found to be effective in eliminating infection. It has been opined that mono-drug therapies fail to eliminate the tissue forms of Hepatozoon spp., leading to relapses in many cases in companion animals [13]. Stress, in any form, is known to trigger relapse of infection. Hence, it is recommended to follow up on cases of relapse for at least a couple of years [14]. In the current veterinary management, patients are regularly followed up for relapses by undertaking blood and molecular tests. Wild animals exhibit a decent tolerance to many protozoan diseases, including hepatozoonosis, and the infection does not progress to clinical stages. Such carrier animals lead a normal life but may act as a source of infection to other animals in the captive and free range [15]. Animals with hepatozoon infections are prone to opportunistic diseases [16]. Reports from Serengeti highlight the impact of protozoal diseases in co-infection with common viruses such as the Canine Distemper Virus (CDV) [17, 18]. Critical care and needful health management of captive wild animals limit the flaring up of the disease. However, no such provisions are available in the wild, and wild animals in the free range face critical challenges in securing food, mate, and territory [19]. In the presence of such challenges, thoughts on whether the disease is subclinical, even in the wild, need to be investigated in light of evidence-based studies [20]. A few reports of hepatozoonosis in large felids have been reported in India [3,4,5, 21, 22]; however, very little is known about the impact of this disease in the free range. Very few reports have focused on wild or wild-captured animals from this perspective. The subclinical nature of the disease, limited active sampling and limited post-mortem investigation of dead large wild felids are the primary causes of the limited information available on the disease. There are definite research gaps in the assessment of the impact and prevalence of hepatozoonosis in the free range, as most available data have emerged from captive wildlife. Based on the data, the disease has often been described as self-limiting and effectively treated with drugs such as doxycycline [4, 23]. Typically, clinical disease in felids is characterised by fever, anaemia, lethargy, wasting, muscle pain and bone deformities [4]. Death and clinical disease have been reported in coyotes and hyenas [18]. However, no report of clinical progression in large wild felids has been encountered [24]. However, it is worth pointing out that many studies in companion animals have indicated relapse in cases of hepatozoonosis due to the failure to eliminate the protozoan’s tissue forms [25]. Regressions in wild felids can be critical, as stress is a consistent feature in the free range. Baseline data on the prevalence of the infection in wild felids in the region is lacking. In order to build baseline data, a non-probablility convenience sampling method was utilised to screen wild/orphan or wild captured tigers presented to the Wildlife Research & Training Centre, Gorewada, Nagpur, for hepatozoonosis, trypanosomosis, babesiosis, theileriosis, ehrlichiosis and Anaplasma platys by blood smear and molecular methods.
Methods
Blood/ tissue sample collection, smear and PCR examination
Blood samples (n = 21) and tissue samples (n = 5) were collected from 26 wild capture/zoo-born or dead tigers during the quarantine period/postmortem examination. Permission for the same was obtained from the Principal Chief Conservator of Forests & Chief Wildlife Warden, Maharashtra State, as per the provisions of the Wildlife Protection Act, 1972. Blood was aseptically collected from the lateral coccygeal vein following physical restraint in a squeeze cage. Blood smear examination using Leishman and Giemsa staining along with Polymerase Chain Reaction (PCR), was conducted for the detection of hepatozoonosis. Alongside the samples were also screened for trypanosomosis, babesiosis, theileriosis, ehrlichiosis and Anaplasma platys. Blood and serum samples collected between January 2020 and January 2023 were examined using an automated hematological and biochemical analyzer (Abaxis Ltd, California, USA) for routine blood and serum parameters. DNA was isolated from the blood sample using the DNeasy® Blood and Tissue Kit (Qiagen Inc., MD, USA) according to the manufacturer’s instructions. Polymerase Chain Reaction (PCR) was performed using the primer pair Hep-F 5’-ATACATGAGCAAAATCTCAAC-3’ and Hep-R 5’-CTTATTATTCCATGCTGCAG-3’ targeting the 16 S ribosomal RNA [26]. Details of the primers employed for the detection of protozoan diseases under the study are provided in Table 1. Tissue samples were collected during post-mortem examination of five carcasses (Table 2 Column No. 9). Organ-wise distribution of the protozoan was studied by DNA isolation and PCR studies using the primers mentioned above. The amplicon was purified using the QIAquick PCR Purification Kit (Qiagen Inc, MD, USA).
Sequencing, phylogenetic and statistical analysis
The purified amplicon was sequenced by an outsourced service provider (Eurofins Pvt. Ltd., Bangalore, India), and the sequences were compared with other reported sequences using the nBLAST tool from the National Center for Biotechnology Information (NCBI) public domain DNA database. The sequences were deposited in the NCBI database using BankIt, and accession numbers were assigned to the sequences. Phylogenetic analysis was performed using Mega X software using neighbour joining method with a bootstrap value of 1000 replications to ensure tree consistency [27]. The data for blood parameters was analyzed by using independent ‘t’ test and a Chi-squared test was employed to estimate the significance of the data for positivity rates.
Clinical management
The clinical management of the tiger cub (TTC1) showing clinical signs was undertaken with a regime consisting of oxytetracycline (10 mg/ kg) and supportive therapy in the form of hepatoprotectants, hematinics, vitamins and probiotics. The tigers (n = 7) found positive were monitored closely for the changes in feeding, behaviour, activity and alertness. In case of any deviation, samples were collected and screened for routine blood and serum examination and molecular assay for protozoans. The samples were otherwise screened quarterly. The tigers under observation received routine vaccination (feline calicivirus, feline rhinotracheitis, feline panleukopenia and rabies) deworming, vitamin and mineral supplementation as per the Central Zoo Authority (CZA) norms.
Results
Blood smear examination with Leishman staining revealed the presence of gamonts in the neutrophils in the blood smear of two tigers (2/26) (Fig. 1), the smear was found to be negative for presence of any intermediate forms of Hepatozoon spp. in rest of the tigers. The PCR analysis produced expected amplification of approximately 650 bp in twelve samples indicating a positive result. The tissue distribution studies indicated uniform distribution of the protozoan in the tissue of the tiger including the liver, spleen, heart, intestine, kidney, lungs and bone marrow (Fig. 2). As shown in Table 2, the accession numbers were assigned to twelve H. felis sequences that were the subject of the investigation.
Phylogenetic analysis was carried out using sequences of Hepatozoon spp. reported from companion and wild animals. The sequences reported from tigers were preferentially included in the study. A total of 46 sequences were included in the study (Table 3). The phylogenetic study identified six major clades with each sub-species maintaining its intraclade identity. Plasmodium vivax formed a distinct outgroup (Fig. 3).
The positivity rate was estimated based on age, sex, geographical origin and time spent in captivity. The age group of 0–3 years reported the highest positivity rate of 66.66%, while 3–7 years reported a positivity rate 42.85%. All the cases found positive were reported from the age group of 0–7 years; Males exhibited a positivity rate of 58.33% while it was 35.71% in females (Table 4). The statistical analysis revealed no significant difference between various blood parameters (Table 5). Also, there was no significant difference in positivity rates between sex, age, geographical origin and time in captivity by Chi square test (Table 6).
The tiger cub (TTC1) treated with oxytetracycline and supportive therapy recovered from the infection after 40 days. The cub tested negative by PCR test and was continuously monitored for two years. Seven tigers that tested positive only by PCR test continued to be positive at each screening without any clinical signs. All the tigers tested negative for trypanosomosis, babesiosis, theileriosis, ehrlichiosis and Anaplasma platys.
Discussion
In majority of the countries in Europe, America and Africa, randomised samples can be collected during the hunting season, road kills, post mortem examination and other such avenues. Under the Indian context, hunting of wildlife is totally prohibited and there is a limited access to road kills and post mortem of wildlife due to remote location and stringent law enforcement. As a result the current study was designed to provide the basic positivity rate for the Vidarbha region of Maharashtra. Previous studies have clearly pointed out that hepatozoonosis is majorly subclinical unless age, stress, co-infection and immunosuppression dictate otherwise [28, 29]. Recent reports on African Wild Dogs from Kruger National Park revealed a high prevalence of 88.88% (n = 54) [30]. Deaths due to the infection have been reported in young hyena cubs [15]. Prevalence studies reported from South Africa have pointed out the high prevalence of 40.99% (n = 23) among wild felids in the region [31]; also, similar studies have pointed out a high prevalence (38–61%) of hepatozoonosis in wild carnivores from Zambia [32]. Reports from Serengeti highlight the role of stressors in the clinical outcome of protozoal diseases in case of co-infection with other pathogens, including viruses [33]. Factors like co-infection, climatic extremes, the season of tick abundance and immunosuppression play a vital role in the outcome of the infection. The outcome of the disease also seems to be governed by the cub’s age and its immune status. Maternal immunity appears to play an essential role in the upsurge of infection in young cubs, and cubs that are separated from their mothers or orphans were found to be more prone to the infection, indicating the vital role of passive innate immunity [34]. Tissue forms have been considered important in the relapse of infection. Relapses have been reported in many companion animals, like dogs and cats. The tissues collected from five dead tigers were processed to study the tissue distribution of Hepatozoon spp. The PCR studies indicated uniform tissue distribution throughout the visceral organs. Tissue forms are crucial in the clinical management of hepatozoonosis as they trigger relapses. Relapses can be critical in endangered wildlife, and such animals can act as a source of infection to others in the wild or captivity. Various molecules like toltrazuril have also been used as therapeutic agents with limited success [35]. Ponazuril has been used successfully in treating H. americanum [36].
One tiger (TTC1) showed clinical signs characterised by anaemia, hypoproteinemia, and elevated AST and ALT values (Table 4). The animal was treated with oxytetracycline 10 mg/ kg IV owing to the low haemoglobin concentration and inability to administer doxycycline orally. The blood smear and PCR test was negative on day 40, and there was a significant improvement in the blood parameters in the affected tiger. The tiger was found active with the restoration of appetite and normal behaviour. The tiger was regularly screened for relapses considering the nature of the disease [25]. Also, a nine-month-old tiger cub (TCP) found dead in one of the protected areas of India was found to be positive for hepatozoonosis, though the tiger’s death could not be attributed to hepatozoonosis. The consideration of hepatozoonosis as a subclinical diseases based on the data available for companion or captive wild animals needs serious reconsideration. In the current study a clinical case in a tiger cub was diagnosed and successfully treated providing evidence that hepatozoonosis can lead to clinical manifestation in young large cats.
The phylogenetic study revealed species specific clade distribution with H. felis occupying the clade I and clade V. It is worth mentioning that sequences OK036954, OK036951, OK036961, OM462674, OM462703 and OM462842 were placed in clade I along with sequences of H. felis reported from India including the Trivandrum Zoo, (Accession No. OL852087 [Panthera tigris]) and Laboratory for Conservation of Endangered Species, Hyderabad (LaCONES) (Accession No. HQ829445 [Panthera tigris]; Accession No. JN584475 [Felis domesticus]) and Etawah Accession No. KX017290 [Panthera leo] including sequences of H. felis from a diverse range of taxa. However the clade V was dominated by sequences reported in tigers under this study. Previous research has suggested that domestic and wild cats can be infected by different genotypes of H. felis. The results align with the findings of the reference study, which suggested that cats on Maio Island, Republic of Cape Verde, have two distinct circulating genotypes of H. felis [37]. The statistical analysis using‘t’ test revealed no significant difference between various blood parameters among the male and female tigers. The Chi- squared test for positivity rates between sex, age, geographical origin or time in captivity was non-significant probably due to small data set.
Out of the nine subclinical tiger cases, seven were monitored for clinical progression or otherwise. The blood and serum parameters were normal except for slight elevation of liver function parameters AST (Aspartate Transaminase) and ALT (Alanine Transaminase). The spike in liver enzymes can be attributed to the inflammatory response to the hepatic invasion by the intermediate forms of Hepatozoon sp. The AST elevation in wild cats can be in response to muscle injury or kidney injury. Haemolysis due to improper blood collection technique could also result in the elevation of AST values. In the current context, the elevation was considered in context with the kidney function test and visible clinical presentation of the patient. The tigers were clinically normal and did not exhibit any illness or distress. During the follow-up screening all the tigers tested positive by PCR with no deviation in the complete blood count and serum biochemistry. The subclinical tigers were observed in captivity since January 2020; blood samples of the animals were screened every quarterly to monitor the progression of the disease. The tigers continued to harbour the infection without any clinical manifestations. The tigers received all management care like vaccination, health screening and deworming, and a balanced diet during captivity. The infection in adult tigers is majorly subclinical, and good managemental practices in captivity can prolong life and ensure a quality life. However, in the free range, uncertain factors like circulating viral diseases, tick population upsurge, vector-borne diseases and environmental stressors etc., can influence the outcome of the disease. Thus, whether the disease is subclinical even in the free-range needs affirmation through a detailed investigation of tigers at all possible avenues.
Conclusion
Hepatozoonosis has always been considered a subclinical infection, and the current study provides evidence of clinical disease in a wild-captured tiger cub. Though the disease in rest of the observed tigers was subclinical, the study clearly opines that the outcome depends on many concurrent factors like age. The status of the infection in wild animals in the free range needs to be reviewed as the disease is widely prevalent in the free range. The current study determined the positivity rate and provided the basic data on the impact of hepatozoonosis on tigers from Central India. The data on the clinical outcome of the infection in wild tigers is definitely lacking. Studies that can further clarify the impact of the infection in wild endangered felids have considerable implications for conservation efforts.
Data availability
The sequence identified in the study is available in the public domain database of NCBI under Accession No. OK036954, OK036951, OM462674, OM462842, OQ931343, OK036961, OQ931338, OM462703, OQ938573, OQ931242, OQ931244 and OQ931243.
https://www.ncbi.nlm.nih.gov/nuccore/OK036954.
https://www.ncbi.nlm.nih.gov/nuccore/OK036951.
https://www.ncbi.nlm.nih.gov/nuccore/OM462674.
https://www.ncbi.nlm.nih.gov/nuccore/OM462842.
https://www.ncbi.nlm.nih.gov/nuccore/OQ931343.
https://www.ncbi.nlm.nih.gov/nuccore/OK036961.
https://www.ncbi.nlm.nih.gov/nuccore/OQ931338.
https://www.ncbi.nlm.nih.gov/nuccore/OM462703.
https://www.ncbi.nlm.nih.gov/nuccore/OQ938573.
https://www.ncbi.nlm.nih.gov/nuccore/OQ931242.
Abbreviations
- DNA:
-
Deoxyribose Nucleic Acid
- NCBI:
-
National Center for Biotechnology Information
- PCR:
-
Polymerase Chain Reaction
- AST:
-
Aspartate Transaminase
- ALT:
-
Alanine Transaminase
References
Jhala YV. Status of tigers, co-predators and prey in India, 2010. National Tiger Conservation Authority, Government of India; 2011.
Geurden T, Becskei C, Six RH, Maeder S, Latrofa MS, Otranto D, Farkas R. Detection of tick-borne pathogens in ticks from dogs and cats in different European countries. Ticks tick-borne Dis. 2018;9(6):1431–6.
Pawar RM, Poornachandar A, Srinivas P, Rao KR, Lakshmikantan U, Shivaji S. Molecular characterization of Hepatozoon spp. infection in endangered Indian wild felids and canids. Vet Parasitol. 2012;186(3–4):475–9.
Kolangath SM, Upadhye SV, Dhoot VM, Pawshe MD. Molecular evidence of Hepatozoon felis infection in Wild Captured Royal Bengal Tiger Cub (Panthera tigris tigris). Indian J Anim Res. 2022;1:6.
Kolangath SM, Upadhye SV, Dhoot VM, Pawshe MD, Shalini AS, Kolangath RM. Molecular investigation and clinical management of Hepatozoon canis infection in an Indian jackal–a case report. BMC Vet Res. 2022;18(1):1–8.
Giannelli A, Lia RP, Annoscia G, Buonavoglia C, Lorusso E, Dantas-Torres F, Baneth G, Otranto D. Rhipicephalus turanicus, a new vector of Hepatozoon canis. Parasitology. 2017;144(6):730–7.
Andersson M, Turcitu MA, Stefanache M, Tamba P, Barbuceanu F, Chitimia L. First evidence of Anaplasma platys and Hepatozoon canis co-infection in a dog from Romania–a case report. Ticks tick-borne Dis. 2013;4(4):317–9.
Morgado FN, Cavalcanti AD, Miranda LH, O’Dwyer LH, Silva MR, Menezes RC, Andrade da Silva AV, Boité MC, Cupolillo E, Porrozzi R. Hepatozoon canis and Leishmania spp. coinfection in dogs diagnosed with visceral leishmaniasis. Revista Brasileira De Parasitol Veterinária. 2016;25:450–8.
Hornok S, Boldogh SA, Takács N, Kontschán J, Szekeres S, Sós E, Sándor AD, Wang Y, Tuska-Szalay B. Molecular epidemiological study on ticks and tick-borne protozoan parasites (Apicomplexa: Cytauxzoon and Hepatozoon spp.) from wild cats (Felis silvestris), Mustelidae and red squirrels (Sciurus vulgaris) in central Europe. Hung Parasites Vectors. 2022;15(1):1–1.
Alic A, Šupić J, Goletić T, Rešidbegović E, Lutvikadić I, Hodžić A. A unique case of fatal Coinfection caused by Leptospira spp. and Hepatozoon canis in a Red Fox Cub (Vulpes vulpes). Pathogens. 2021;11(1):11.
Bhusri B, Lekcharoen P, Changbunjong T. First detection and molecular identification of Babesia gibsoni and Hepatozoon canis in an Asiatic wild dog (Cuon alpinus) from Thailand. Int J Parasitology: Parasites Wildl. 2022;17:225–9.
Tresamol PV, Rincy KM, Arthi A, Pillai UN, Ajithkumar S. Molecular diagnosis and therapeutic management of Hepatozoon canis infection in Dogs. Indian J Canine Pract Volume. 2022;14(1).
O’Dwyer LH, Saito ME, Hasegawa MY, Kohayagawa A. Tissue stages of Hepatozoon canis in naturally infected dogs from São Paulo State, Brazil. Parasitol Res. 2004;94:240–2.
Sakuma M, Nakahara Y, Suzuki H, Uchimura M, Sekiya Z, Setoguchi A, Endo Y. A case report: a dog with acute onset of Hepatozoon canis infection. J Vet Med Sci. 2009;71(6):835–8.
Gimenez C, Casado N, Criado-Fornelio Á, de Miguel FÁ, Dominguez-Penafiel G. A molecular survey of Piroplasmida and Hepatozoon isolated from domestic and wild animals in Burgos (northern Spain). Vet Parasitol. 2009;162(1–2):147–50.
Baneth G, Aroch I, Tal N, Harrus S. Hepatozoon species infection in domestic cats: a retrospective study. Vet Parasitol. 1998;79(2):123–33.
Averbeck GA, Bjork KE, Packer C, Herbst L. Prevalence of hematozoans in lions (Panthera leo) and cheetah (Acinonyx jubatus) in Serengeti National Park and Ngorongoro Crater, Tanzania. J Wildl Dis. 1990;26(3):392–4.
East ML, Wibbelt G, Lieckfeldt D, Ludwig A, Goller K, Wilhelm K, Schares G, Thierer D, Hofer H. A Hepatozoon species genetically distinct from H. canis infecting spotted hyenas in the Serengeti ecosystem, Tanzania. J Wildl Dis. 2008;44(1):45–52.
Morand-Ferron J, Cole EF, Quinn JL. Studying the evolutionary ecology of cognition in the wild: a review of practical and conceptual challenges. Biol Rev. 2016;91(2):367–89.
Uiterwijk M, Vojta L, Šprem N, Beck A, Jurković D, Kik M, Duscher GG, Hodžić A, Reljić S, Sprong H, Beck R. Diversity of Hepatozoon species in wild mammals and ticks in Europe. Parasites Vectors. 2023;16(1):1–2.
Bhusri B, Sariya L, Mongkolphan C, Suksai P, Kaewchot S, Changbunjong T. Molecular characterization of Hepatozoon felis in Rhipicephalus sanguineus ticks infested on captive lions (Panthera leo). J Parasitic Dis. 2017;41(3):903–7.
Rafiqi SI, Kumar S, Reena KK, Garg R, Ram H, Karikalan M, Mahendran K, Pawde AM, Sharma AK, Banerjee P. Molecular characterization of Hepatozoon sp. and Babesia sp. isolated from endangered asiatic lion (Panthera leo persica). Indian J Anim Sci. 2018;88:662–7.
Iatta R, Natale A, Ravagnan S, Mendoza-Roldan J, Zatelli A, Cavalera MA, Nachum-Biala Y, Baneth G, Otranto D. Zoonotic and vector-borne pathogens in tigers from a wildlife safari park, Italy. Int J Parasitology: Parasites Wildl. 2020;12:1–7.
Cerreta AJ, Yang TS, Ramsay EC, Birkenheuer AJ, Rahoi D, Qurollo B, Wilson J, Cushing AC. Detection of vector-borne infections in lions and tigers at two zoos in Tennessee and Oklahoma, USA. J Zoo Wildl Med. 2022;53(1):50–9.
Macintire DK, Vincent-Johnson N, Dillon AR, Blagburn B, Lindsay D, Whitley EM, Banfield C. Hepatozoonosis in dogs: 22 cases (1989–1994). J Am Vet Med Assoc. 1997;210(7):916–22.
Inokuma H, Okuda M, Ohno K, Shimoda K, Onishi T. Analysis of the 18S rRNA gene sequence of a Hepatozoon detected in two Japanese dogs. Vet Parasitol. 2002;106(3):265–71.
Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol. 2018;35(6):1547.
Khoshnegah J, Mohri M, Mirshahi A, Mousavi SJ. Detection of Hepatozoon sp. in a persian leopard (Panthera pardus Ciscaucasica). J Wildl Dis. 2012;48(3):776–80.
Modry D, Beck R, Hrazdilová K, Baneth G. A review of methods for detection of Hepatozoon infection in carnivores and arthropod vectors. Vector-Borne Zoonotic Dis. 2017;17(1):66–72.
Netherlands EC, Stroebel C, Du Preez LH, Shabangu N, Matjila PT, Van Schalkwyk OL, Penzhorn BL. Molecular confirmation of high prevalence of species of Hepatozoon infection in free-ranging African wild dogs (Lycaon pictus) in the Kruger National Park, South Africa. Int J Parasitology: Parasites Wildl. 2021;14:335–40.
Harris DJ, Sergiadou D, Halajian A, Swanepoel LH, Roux F. Molecular screening indicates high prevalence and mixed infections of Hepatozoon parasites in wild felines from South Africa. J S Afr Vet Assoc. 2020;91(1):1–5.
Williams BM, Berentsen A, Shock BC, Teixiera M, Dunbar MR, Becker MS, Yabsley MJ. Prevalence and diversity of Babesia, Hepatozoon, Ehrlichia, and Bartonella in wild and domestic carnivores from Zambia, Africa. Parasitol Res. 2014;113(3):911–8.
Munson L, Terio KA, Kock R, Mlengeya T, Roelke ME, Dubovi E, Summers B, Sinclair AR, Packer C. Climate extremes promote fatal co-infections during canine distemper epidemics in African lions. PLoS ONE. 2008;3(6):e2545.
Uilenberg G. International collaborative research: significance of tick-borne hemoparasitic diseases to world animal health. Vet Parasitol. 1995;57(1–3):19–41.
Krampitz HE, Haberkorn A. Experimental treatment of Hepatozoon infections with the anticoccidial agent toltrazuril. J Veterinary Med Ser B. 1988;35(1–10):131–7.
Allen KE, Little SE, Johnson EM, Hostetler J, Panciera RJ, Ewing SA. Treatment of Hepatozoon americanum infection: review of the literature and experimental evaluation of efficacy. Veterinary Therapeutics: Res Appl Veterinary Med. 2010;11(4):E1–8.
Pereira C, Maia JP, Marcos R, Luzzago C, Puente-Payo P, Dall’Ara P, Faustino A, Lauzi S. Molecular detection of Hepatozoon felis in cats from Maio Island, Republic of Cape Verde and global distribution of feline hepatozoonosis. Parasites Vectors. 2019;12:1–9.
Criado-Fornelio A, Martinez-Marcos A, Buling-Saraña A, Barba-Carretero JC. Molecular studies on Babesia, Theileria and Hepatozoon in southern Europe: part I. Epizootiological aspects. Vet Parasitol. 2003;113(3–4):189–201.
Desquesnes M, McLaughlin G, Zoungrana A, Dávila AM. Detection and identification of Trypanosoma of African livestock through a single PCR based on internal transcribed spacer 1 of rDNA. Int J Parasitol. 2001;31(5–6):610–4.
Gal A, Loeb E, Yisaschar-Mekuzas Y, Baneth G. Detection of Ehrlichia canis by PCR in different tissues obtained during necropsy from dogs surveyed for naturally occurring canine monocytic ehrlichiosis. Vet J. 2008;175(2):212–7.
Brown GK, Martin AR, Roberts TK, Aitken RJ. Detection of Ehrlichia platys in dogs in Australia. Aust Vet J. 2001;79(8):554–8.
Mitková B, Hrazdilová K, Steinbauer V, D’Amico G, Mihalca AD, Modrý D. Autochthonous Hepatozoon infection in hunting dogs and foxes from the Czech Republic. Parasitol Res. 2016;115(11):4167–71.
Criado-Fornelio A, Rey-Valeiron C, Buling A, Barba-Carretero JC, Jefferies R, Irwin P. New advances in molecular epizootiology of canine hematic protozoa from Venezuela, Thailand and Spain. Vet Parasitol. 2007;144(3–4):261–9.
Orkun Ö, Emir H. Identification of tick-borne pathogens in ticks collected from wild animals in Turkey. Parasitol Res. 2020;119(9):3083–91.
Pawar RM, Poornachandar A, Arun AS, Manikandan S, Shivaji S. Molecular prevalence and characterization of Hepatozoon ursi infection in Indian sloth bears (Melursus ursinus). Vet Parasitol. 2011;182(2–4):329–32.
Hodzic A, Alić A, Prašović S, Otranto D, Baneth G, Duscher GG. Hepatozoon silvestris sp. nov.: morphological and molecular characterization of a new species of Hepatozoon (Adeleorina: Hepatozoidae) from the European wild cat (Felis silvestris silvestris). Parasitology. 2017;144(5):650–61.
Acknowledgements
The authors acknowledge the kind approval of the Principal Chief Conservator of Forest (Wildlife) & Chief Wildlife Warden, Maharashtra State, for carrying out the research work. Forest Development Corporation of Maharashtra Ltd., Nagpur and Office of the Divisional Manager, Gorewada Project, Nagpur, for the facilities provided to undertake the research. Director, Wildlife Research & Training Centre to facilitate the research work at WRTC, Gorewada, Nagpur.
Funding
The authors self-funded the study. The Corresponding author is not in receipt of any funding from research agencies in India or abroad.
Author information
Authors and Affiliations
Contributions
KSM major contributor and involved in all phases of research, including writing the manuscript, performing the PCR, sequencing, phylogenetic analysis. PMD and USV supervised the study, collected samples, transported them to the lab, contributed to writing. DVM and PMS carried out the statistical analysis. KRM performed phylogenetic analysis and assisted in manuscript preparation. All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Samples from the post mortem examination of tiger cub under reference No. 21 of Table 2 has been collected as per the request letter no Desk-3/ Vigilance/DD/ PTR/390/ 22–23, Nagpur dated 06/05/2022. As per the existing Wildlife Protection Act, 1972 permission from Principal Chief Conservator of Forest (Wildlife), Maharashtra State was sought to vide No. Desk-22(8)/Res/CR-59(19–20)/3838/19–20, Nagpur, date 15 January 2020; vide No. Desk-22(8)/Res/CR-59(19–20)/2370/20–21, Nagpur, date 07 January 2021 and vide No. Desk-22(8)/Res/CR-59(19–20)/2565/2021-22, Nagpur, date 18 January 2022 for the study and publication of scientific findings. All the sample collection during the study has been executed as per ARRIVE guidelines.
Consent for publication
Not applicable.
Reporting animal experiments
No experiments have been carried out on animals and the samples were collected for the clinical management of wild animals wherein required permissions as per the provisions of the Wildlife Protection Act, 1972 have been obtained from the PCCF (Wildlife) of Maharashtra State (India). However, sample collection has been undertaken as per the ARRIVE guidelines.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Kolangath, S.M., Pawshe, M.D., Upadhye, S.V. et al. Molecular evidence of hepatozoonosis in tigers of Vidarbha region of Maharashtra State of India. BMC Vet Res 20, 387 (2024). https://doi.org/10.1186/s12917-024-04224-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12917-024-04224-3